Financhill
Buy
61

PHAR Quote, Financials, Valuation and Earnings

Last price:
$9.71
Seasonality move :
-7.31%
Day range:
$9.71 - $9.95
52-week range:
$6.65 - $13.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.52x
P/B ratio:
2.92x
Volume:
2.3K
Avg. volume:
6.8K
1-year change:
-25.31%
Market cap:
$658.7M
Revenue:
$245.3M
EPS (TTM):
-$0.27

Earnings Data

Next earnings date for PHAR
Mar 14
2025
Most recent earnings per share
-$0.02
Missed by $0.02
(Oct 24/2024)
Consensus Estimate
-$0.00
(Oct 24/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PHAR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $64M -- -- -$0.01 --
03/14/2025 Q4 $80.6M -- -- $0.01 --
10/24/2024 Q3 $76M $74.8M -$0.02 -$0.00 -$0.02
08/01/2024 Q2 $72M $74.1M -$0.01 -$0.00 -$0.01
05/08/2024 Q1 $69.9M $55.6M -$0.19 $0.01 -$0.20
03/14/2024 Q4 -- $81.2M -$0.05 $0.00 -$0.05
10/26/2023 Q3 -- -- $0.05 -$0.01 $0.06
08/03/2023 Q2 -- -- $0.02 -$0.02 $0.04
05/11/2023 Q1 -- -- -$0.19 -- --
03/16/2023 Q4 -- -- -$0.22 -- --
10/27/2022 Q3 -- -- $0.13 -- --
08/04/2022 Q2 -- -- $0.22 -- --
05/12/2022 Q1 -- -- $0.05 -- --
03/17/2022 Q4 -- -- $0.03 -- --
10/28/2021 Q3 -- -- -$0.01 -- --
08/05/2021 Q2 -- -- $0.06 -- --
05/13/2021 Q1 -- -- $0.13 -- --
03/04/2021 Q4 -- -- $0.11 -- --
09/30/2020 Q3 -- -- $0.13 -- --
06/30/2020 Q2 -- -- $0.16 -- --
03/31/2020 Q1 -- -- $0.12 -- --
12/31/2019 Q4 -- -- $0.22 -- --
09/30/2019 Q3 -- -- $0.17 -- --
06/30/2019 Q2 -- -- $0.12 -- --
03/31/2019 Q1 -- -- $0.11 -- --
12/31/2018 Q4 -- -- $0.19 -- --
09/30/2018 Q3 -- -- $0.09 -- --
06/30/2018 Q2 -- -- $0.05 -- --
03/31/2018 Q1 -- -- $0.10 -- --
12/31/2017 Q4 -- -- -$0.92 -- --
09/30/2017 Q3 -- -- -$0.20 -- --
06/30/2017 Q2 -- -- -$0.60 -- --
03/31/2017 Q1 -- -- -$0.13 -- --
12/31/2016 Q4 -- -- -$0.16 -- --
09/30/2016 Q3 -- -- -$0.10 -- --
06/30/2016 Q2 -- -- -$0.09 -- --
03/31/2016 Q1 -- -- -$0.09 -- --
12/31/2015 Q4 -- -- -$0.11 -- --
09/30/2015 Q3 -- -- -$0.07 -- --
06/30/2015 Q2 -- -- -$0.07 -- --
03/31/2015 Q1 -- -- -$0.03 -- --

Pharming Group Earnings Questions

  • How Much did Pharming Group Generate in Revenue Last Quarter?

    Pharming Group reported $74.8M worth of top line sales in its most recent quarter.

  • Did Pharming Group Beat Earnings Last Quarter?

    Pharming Group announced earnings per share of -$0.02 which represents a miss of analyst forecast a -$0.00 per share.

  • Is Pharming Group Profitable?

    Pharming Group reported $68M that represents $1.32 per share over the last quarter.

  • What is the Analyst Consensus for Pharming Group EPS Next Year?

    Pharming Group's earnings are forecast to decrease from -$0.16 per share to -$0.01 per share next year representing a decrease of -92.19%.

  • When is Pharming Group's Earnings Date?

    Pharming Group's next earnings date is March 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock Overvalued?
Is Broadcom Stock Overvalued?

The semiconductor company Broadcom Inc. (NASDAQ:AVGO) is having a stellar…

4 Top Dividend Stocks to Buy Now
4 Top Dividend Stocks to Buy Now

If you’re looking for steady income, dividend stocks are a…

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
87
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
1
MCY alert for Jan 11

Mercury General [MCY] is down 19.87% over the past day.

Buy
84
ATZAF alert for Jan 11

Aritzia [ATZAF] is up 17.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock